Efficacy of escitalopram treatment i acute stroke and the role of specific genotypes in stroke

• Conditions: Stroke; MedDRA version: 14.1Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 10029205 - Nervous system disorders; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2011-005541-12-DK
• Lead Sponsor: Grethe Andersen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-27
• Last Update Posted: 3 July 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age over 18 years
Clinically verified first ever ischemic stroke
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 300
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 300

Exclusion Criteria

Hemoragic stroke
Dementia
Antidepressant treatment within 30 days prior to inclusion
Contraindications to SSRI treatment
Liver/renal failure
QTc prolongation (more than 500 ms)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified